Well women exam Flashcards
Gardasil
months 0,2,6
1st GYN visit
13-15
only pelvic if sexually active or symptomatic
HIV testing
routine from 19-63
mammogram
every 1-2 years at 40 and every year at 50
colon cancer
colonoscopy
flex sig every 5
Fecal immunochemical testing every year
barium enema every 5
TSH screening
TSH screening every 5 years at age 50
Lipid screening
every 5 years at age 45
Fasting Glucose
every 3 years at age 45
Bone Density
at 65 or risk factors
Routine Screening at 20- up to 25- 40- 45- 50- 65-
20- cholesterol with increased risk for CHD (obese, smoker, Family Hx, Diabetes)
up to 25- gc/chlam
40-mammogram q1-2
45- Lipids q5 /Glucose q3/Colon cancer for AA
50- TSH q 5/colon cancer screening.
65- Bone density (not more than q 2)
HIV and pap smears
q 6 months in 1st year
HPV cotesting is not recommended
Adult Immunization
Td q 10 years and 1 dose of Tdap
MMR 1-2 doses between 19-49, 1 dose after 50
Herpes Zoster 1 dose>60 years old
Pneumonia- at 65
Weight Loss Drugs
Orlistat: inhibits fat absorption Phentermine: appetite suppressant Sobutramine: appetite suppressant Diethylpropion : appetite suppressant Loracaserin HCl (Belviq) : appetite suppressant Qsymia (Phenteramine + Topiramate [antiseizure]) \: appetite suppressant
When to consider bariatric Surgery
BMI > 40 or BMI > 35 with significant comorbidities
When to use statins
Four groups most likely to benefit from statin therapy are identified:
- Patients with any form of clinical ASCVD
- Patients with primary LDL-C levels of 190 mg per dL or greater
- Patients with diabetes mellitus, 40 to 75 years of age, with LDL-C levels of 70 to 189 mg per dL
- Patients without diabetes, 40 to 75 years of age, with an estimated 10-year ASCVD risk ≥ 7.5%